A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

NCT07079631 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

482

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

BIOLOGICAL: BNT314
DRUG: BNT327
DRUG: SoC chemotherapy treatment 1
DRUG: SoC chemotherapy treatment 2
DRUG: Bevacizumab

Sponsor

BioNTech SE

Collaborators

[object Object]